About
ANEUVO is a bioelectronic medical device company dedicated to developing therapies for chronic conditions and disabling injuries that have not responded to traditional treatments. The company aims to restore functional independence and improve the quality of life for patients, particularly those in underserved populations. Headquartered in Los Angeles, CA, ANEUVO leverages advanced biotechnology and expertise in bioelectronic medicine to tackle significant healthcare challenges. The flagship product, the ExaStim® Stimulation System, is designed to help patients recover lost motor function and strength, especially those with spinal cord injuries. This innovative device uses targeted electrical stimulation combined with rehabilitation to enhance recovery. The ExaStim® system has received recognition as a Breakthrough Device by the U.S. FDA and has CE Mark approval in Europe, allowing it to be utilized in various healthcare markets. ANEUVO's focus is on integrating bioelectronic therapies with rehabilitation programs to redefine treatment outcomes for conditions previously deemed untreatable.
Technologies
Keywords
Company Information
-
Employees 22
-
Founded 2016
Location
10940 Wilshire Boulevard, Los Angeles, California, United States, 90024